CSPC Pharmaceutical Group stock

1093 · HKEX · HKD

Compare CSPC Pharmaceutical Group
$7.71Change from previous close: −2.28%Absolute change: −$0.18

Close · November 18, 2026

Price history

−0.26% over the period

1 year: from $7.73 (November 18, 2025) to $7.71 (November 18, 2026), −0.26%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 18, 2026$7.71
October 30, 2026$7.86
September 30, 2026$10.07
August 31, 2026$9.24
July 31, 2026$8.58
June 30, 2026$6.97
May 29, 2026$7.50
April 30, 2026$8.41
March 31, 2026$9.10
February 27, 2026$9.90
January 30, 2026$9.60
December 31, 2025$8.44
November 28, 2025$7.91
November 18, 2025$7.73

At a glance

  • The company

    Manufactures and sells a wide range of pharmaceutical products including branded drugs, bulk pharmaceutical products, and functional foods, primarily in China and internationally

  • Latest results

    Quarter to June 30, 2026 · EPS ¥0.46 (estimate ¥0.16)

TickerLandia's take on CSPC Pharmaceutical Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$6.53
52-wk high$10.96

−29.65% from the 52-week high

Analysts · 24 analysts

Average target$12.67+64.37% vs. price

Buy 21 · Hold 1 · Sell 2 · Buy

TickerLandia Fingerprint: CSPC Pharmaceutical Group

Compared with similar companies: very high financial strength.

Financials and price compared with 25 companies in the drug manufacturers - general industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

CSPC Pharmaceutical Group is cheaper than similar companies

CSPC Pharmaceutical Group's P/E (trailing 12 months): 10.8, −43% against the median of a group of 10 similar companies (18.9).

Compared with 10 similar companies

CSPC Pharmaceutical Group's metrics compared with similar companies
MetricCSPC Pharmaceutical GroupPosition in the groupBand
P/E (trailing 12 months)10.8Low
Forward P/E11.8Low
Operating margin27.9%Middle
ROE20.9%Middle
Debt/equity0.02Low

Grey band: the middle half of the group; tick: the median; dot: CSPC Pharmaceutical Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥12.13B

Latest quarter · Q2 2026

Net income

¥5.23B

Latest quarter · Q2 2026

Quarterly net margin

43.2%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$89.99B
P/E
10.8
EPS
$0.73
Volume
71.58M
Daily trading
€81.14M
Dividend yield
6.61%
Last ex-dividend on October 20, 2026

How CSPC Pharmaceutical Group is changing

All results
  • Revenue grew 0.8% a year on average over the last 5 years

  • Operating margin fell from 21.8% to 15.2%

  • Free cash flow equal to 64% of net income

Returns

CSPC Pharmaceutical Group returns with dividends

$1,000 invested in CSPC Pharmaceutical Group 5 years ago, on November 18, 2021, would be worth $1,137 today with dividends reinvested: +13.68% in total, +2.60% per year. On price alone it would be $928 (−7.22%).

PeriodCSPC Pharmaceutical GroupHang Seng$1,000 becomes
1 month−13.57%−1.51%$864
6 months+1.72%−8.44%$1,017
Year to date−8.65%−8.28%$914
1 year+6.06%−9.34%$1,061
3 years+26.08%+32.23%$1,261
5 years+13.68%−7.15%$1,137
10 years+144.32%+5.21%$2,443

Over the last 6 months it has done better than 40% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Hang Seng: price only. Calculate your investment

The chart in detail

CSPC Pharmaceutical Group: technical analysis

CSPC Pharmaceutical Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 43.2% below its all-time closing high ($13.57, May 28, 2018).

Trend
No clear trend
RSI (14 sessions)
34
Between 30 and 70
vs 200-session average
−11.05%

Support and resistance

Price areas where CSPC Pharmaceutical Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$8.63+11.96%4 touches, last on November 5, 2026
  2. Resistance$8.34+8.17%4 touches, last on August 6, 2026
  3. Resistance$7.98+3.50%3 touches, last on June 1, 2026
  4. Last price$7.71
  5. Support$7.59−1.62%2 touches, last on November 2, 2026
  6. Support$7.21−6.55%2 touches, last on December 16, 2025
  7. Support$6.57−14.83%3 touches, last on June 25, 2026

Volatility and risk

Over the last year it has moved more than the Hang Seng.

Beta (1 year) vs Hang Seng
1.21
Volatility (60 sessions, annualised)
39.7%
Largest fall in the last year
−37.79%

In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

CSPC Pharmaceutical Group: seasonality

Average monthly price change over 33 years

+0.9%Jan+9.5%Feb+1.5%Mar+5.9%Apr+3.2%May−0.7%Jun+1.6%Jul+1.2%Aug+0.1%Sep+0.2%Oct+0.7%Nov−1.2%Dec

Over the last 33 years, the strongest month for CSPC Pharmaceutical Group has been February: +9.54% on average, positive in 24 years out of 32. The weakest has been December: −1.18% on average, positive in 16 years out of 32. November, the current month, has been positive in 15 years out of 32 (+0.69% on average).

Show chart data
MonthAverageMedianPositive years
January+0.93%+2.65%17 of 32
February+9.54%+5.32%24 of 32
March+1.54%−0.93%15 of 32
April+5.90%+2.85%19 of 32
May+3.15%+2.35%18 of 32
June−0.67%−3.40%9 of 32
July+1.58%0.00%13 of 33
August+1.16%0.00%15 of 33
September+0.11%+0.25%17 of 33
October+0.18%+1.80%18 of 33
November+0.69%−0.35%15 of 32
December−1.18%+0.05%16 of 32

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

CSPC Pharmaceutical Group and its competitors

CSPC Pharmaceutical Group serves patients and healthcare providers in Mainland China, other Asian regions, Europe, North America and other international markets, manufacturing and selling finished drugs, bulk products and functional food items. Its portfolio covers stroke, memory impairment, Parkinson's disease, cancer and chemotherapy-related infection support, antibiotics, hypertension, diabetes, osteoporosis, arthritis and pain relief, as well as active pharmaceutical ingredients such as antibiotics, vitamin C and caffeine.

Headquarters
Shijiazhuang, China
Employees
18,626
Founded
1992
Chief executive
Lei Cai
CSPC Pharmaceutical Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
CSPC Pharmaceutical Group1093$11.47B27.9%10.8+1.72%
Astellas Pharma4503$30.89B23.5%12.8+18.37%
Daiichi Sankyo4568$32.83B12.6%18.8+5.65%
Otsuka Holdings4578$41.01B18.0%17.0+9.88%
Chugai Pharmaceutical4519$76.25B48.3%24.1−7.89%
RecordatiREC$12.09B32.6%21.1+2.62%

Same industry or related industries, similar size. Compare CSPC Pharmaceutical Group with its competitors · Full profile